Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Tamoxifen × Clear all

NCT06630325 2026-01-07

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase 2 Active not recruiting

GastrointestinalGenitourinaryGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT06914674 2025-04-06

SPTP

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Recurrence